Literature DB >> 27730101

The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis.

Dat T Tran1, Arto Ohinmaa1, Nguyen X Thanh1, Jonathan G Howlett1, Justin A Ezekowitz1, Finlay A McAlister1, Padma Kaul1.   

Abstract

BACKGROUND: Heart failure is a costly health condition and a major public health concern. We sought to examine the costs of hospital admissions for heart failure between fiscal years 2004 and 2013 in Canada and to model the future costs to 2030.
METHODS: Canadian Institutes for Health Information Discharge Abstract Database was used to identify admissions to hospital with heart failure as the primary diagnosis between fiscal years 2004 and 2013. Multiple linear regression models were used to calculate the trend in prevalence and extrapolate these to 2030. Canadian Institutes for Health Information patient cost estimates were used to identify costs of hospital admissions for heart failure. Generalized linear models were used to estimate average annual costs per heart failure patient. We conducted a sensitivity analysis including all admissions for heart failure in any diagnostic field.
RESULTS: In 2013, 45 600 (95% confidence interval [CI]: 43 800-47 200) patients were admitted with heart failure as the primary diagnosis, accounting for $482 (95% CI $464-$500) million. By 2030, we estimate 54 000 (95% CI 49 000-60 000) patients and costs of $722 (95% CI $650-$801) million, with older adults (age ≥ 80 yr) accounting for 52% of costs. Including admissions for which heart failure was a secondary diagnosis increases the total cost to $2.8 (95% CI $2.6-$3.0) billion in 2030.
INTERPRETATION: As in other developed countries, hospital costs related to heart failure in Canada are on the rise. Older adults are the main consumers of such hospital services. Strategies to improve outpatient care to reduce rates of admission for heart failure are needed.

Entities:  

Year:  2016        PMID: 27730101      PMCID: PMC5047807          DOI: 10.9778/cmajo.20150130

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  14 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  Treating the right patient at the right time: access to heart failure care.

Authors:  H Ross; J Howlett; J Malcolm O Arnold; P Liu; B J O'Neill; J M Brophy; C S Simpson; M M Sholdice; M Knudtson; D B Ross; J Rottger; K Glasgow
Journal:  Can J Cardiol       Date:  2006-07       Impact factor: 5.223

3.  On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada.

Authors:  Helen Johansen; Barbara Strauss; J Malcolm O Arnold; Gordon Moe; Peter Liu
Journal:  Can J Cardiol       Date:  2003-03-31       Impact factor: 5.223

4.  Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.

Authors:  Kathleen T Unroe; Melissa A Greiner; Adrian F Hernandez; David J Whellan; Padma Kaul; Kevin A Schulman; Eric D Peterson; Lesley H Curtis
Journal:  Arch Intern Med       Date:  2010-10-11

Review 5.  Epidemiology and risk profile of heart failure.

Authors:  Anh L Bui; Tamara B Horwich; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2010-11-09       Impact factor: 32.419

6.  Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007.

Authors:  Darwin F Yeung; Nicole K Boom; Helen Guo; Douglas S Lee; Susan E Schultz; Jack V Tu
Journal:  CMAJ       Date:  2012-08-20       Impact factor: 8.262

7.  Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.

Authors:  Paul A Heidenreich; Nancy M Albert; Larry A Allen; David A Bluemke; Javed Butler; Gregg C Fonarow; John S Ikonomidis; Olga Khavjou; Marvin A Konstam; Thomas M Maddox; Graham Nichol; Michael Pham; Ileana L Piña; Justin G Trogdon
Journal:  Circ Heart Fail       Date:  2013-04-24       Impact factor: 8.790

8.  Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.

Authors:  Padma Kaul; Shelby D Reed; Adrian F Hernandez; Jonathan G Howlett; Justin A Ezekowitz; Yanhong Li; Yinggan Zheng; Jean L Rouleau; Randall C Starling; Christopher M O'Connor; Robert M Califf; Paul W Armstrong
Journal:  JACC Heart Fail       Date:  2013-10-23       Impact factor: 12.035

9.  Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.

Authors:  Pardeep S Jhund; Kate Macintyre; Colin R Simpson; James D Lewsey; Simon Stewart; Adam Redpath; James W T Chalmers; Simon Capewell; John J V McMurray
Journal:  Circulation       Date:  2009-01-19       Impact factor: 29.690

10.  National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004.

Authors:  Jack V Tu; Lorelei Nardi; Jiming Fang; Juan Liu; Laila Khalid; Helen Johansen
Journal:  CMAJ       Date:  2009-06-23       Impact factor: 8.262

View more
  25 in total

1.  Effect of early physician follow-up on mortality and subsequent hospital admissions after emergency care for heart failure: a retrospective cohort study.

Authors:  Clare L Atzema; Peter C Austin; Bing Yu; Michael J Schull; Cynthia A Jackevicius; Noah M Ivers; Paula A Rochon; Douglas S Lee
Journal:  CMAJ       Date:  2018-12-17       Impact factor: 8.262

2.  Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients.

Authors:  Aws Almufleh; Jeffrey Marbach; Sharon Chih; Ellamae Stadnick; Ross Davies; Peter Liu; Lisa Mielniczuk
Journal:  Am J Cardiovasc Dis       Date:  2017-12-20

Review 3.  Economic Issues in Heart Failure in the United States.

Authors:  Paul A Heidenreich; Gregg C Fonarow; Yekaterina Opsha; Alexander T Sandhu; Nancy K Sweitzer; Haider J Warraich
Journal:  J Card Fail       Date:  2022-01-24       Impact factor: 6.592

4.  The Current and Future Hospitalization Cost Burden of Syncope in Canada.

Authors:  Dat T Tran; Robert S Sheldon; Padma Kaul; Roopinder K Sandhu
Journal:  CJC Open       Date:  2020-03-04

5.  Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada.

Authors:  Ashlay A Huitema; Alexia Daoust; Kim Anderson; Stephanie Poon; Sean Virani; Michel White; Carlos Rojas-Fernandez; Shelley Zieroth; Robert S McKelvie
Journal:  CJC Open       Date:  2020-04-05

6.  Referral Practices of Cardiologists to Specialist Palliative Care in Canada.

Authors:  Michael J Bonares; Ken Mah; Jane MacIver; Lindsay Hurlburt; Ebru Kaya; Gary Rodin; Heather Ross; Camilla Zimmermann; Kirsten Wentlandt
Journal:  CJC Open       Date:  2020-12-09

7.  Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan.

Authors:  Domingo Pascual-Figal; Rolf Wachter; Michele Senni; Jan Belohlavek; Adele Noè; David Carr; Dmytro Butylin
Journal:  ESC Heart Fail       Date:  2017-12-14

8.  Comparative effectiveness of the different components of care provided in heart failure clinics-protocol for a systematic review and network meta-analysis.

Authors:  Morgan Slater; Joanna Bielecki; Ana Carolina Alba; Lusine Abrahamyan; George Tomlinson; Susanna Mak; Jane MacIver; Shelley Zieroth; Douglas Lee; William Wong; Murray Krahn; Heather Ross; Valeria E Rac
Journal:  Syst Rev       Date:  2019-02-02

9.  Patient experiences using a novel tool to improve care transitions in patients with heart failure: a qualitative analysis.

Authors:  Toni Schofield; R Sacha Bhatia; Cindy Yin; Shoshana Hahn-Goldberg; Karen Okrainec
Journal:  BMJ Open       Date:  2019-06-24       Impact factor: 2.692

Review 10.  Medications that reduce emergency hospital admissions: an overview of systematic reviews and prioritisation of treatments.

Authors:  Niklas Bobrovitz; Carl Heneghan; Igho Onakpoya; Benjamin Fletcher; Dylan Collins; Alice Tompson; Joseph Lee; David Nunan; Rebecca Fisher; Brittney Scott; Jack O'Sullivan; Oliver Van Hecke; Brian D Nicholson; Sarah Stevens; Nia Roberts; Kamal R Mahtani
Journal:  BMC Med       Date:  2018-07-26       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.